News

Among 1434 Japanese HIV-infected men who had not been vaccinated against Hepatitis-B (HBV) 354 had no serological markers of HBV infection. In this group acquisition of HBV was ...

Another failed vaccine trial: HVTN 505 is a placebo controlled trial of an HIV-1 DNA plasmid vaccine and HIV-1 recombinant adenoviral vector in MSM and transgender persons. The DNA ...

A child whose mother had an unknown HIV-infection and hat not received any ART during pregnancy had positive HIV-RNA and HIV-DNA in very early samples. 31 hours after birth triple ...

The New York State Department of Health AIDS institute in collaboration with Johns Hopkins University Division of Infectious Diseases has issued new guidelines for HIV prophylaxis ...

In a study of cryptococcal meningitis (CM) in Uganda and South Africa patients were randomized to early initiation of ART within 2 weeks or deferred therapy until at least 5 weeks ...

20 HIV infected MSM with acute HCV GT 1 infection were treated with a triple combination of telaprevir in combination with peginterferon/ribavirin for 12 weeks. Treatment was initiated ...

A polyurethane vaginal ring containing 130 mg of TDF made of hydrophilic elastomer showed complete protection in 6 female macaques that were challenged for up to 16 weeks with SHIV. ...

A total of 80 patients with HCV GT1 monoinfection with previous null response to standard therapy were included in a four arms randomized study of sofosbuvir and simeprivir with or ...

In the Optimize study twice daily telaprevir was compared to the approved dosage of three times daily in treatment naïve GT 1 patients in combination with pegylated interferon and...

Patients with GT1 infection treated with boceprevir in combination with ribavirin and pegylated interferon who developed anemia with Hbg less than 10 g/dl were randomized to either ...

Pages